Syndax Pharmaceuticals SNDX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's operating lease ROU assets?
- Syndax Pharmaceuticals (SNDX) reported operating lease ROU assets of $1.21M in Q1 2026.
- How has Syndax Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Syndax Pharmaceuticals's operating lease ROU assets decreased by 32.7% year-over-year, from $1.8M to $1.21M.
- What is the long-term trend for Syndax Pharmaceuticals's operating lease ROU assets?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's operating lease ROU assets has grown at a 35.9% compound annual growth rate (CAGR), from $290K to $1.34M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.